撒哈拉以南非洲HIV感染者同日启动抗逆转录病毒治疗作为失访和病毒抑制的预测因素
该研究纳入撒哈拉以南非洲11个国家63个中心的29017例初治HIV成人感染者,评估同日启动抗逆转录病毒治疗(ART)与失访及病毒抑制的关系。同日启动ART者失访率高于延迟启动者(27.7% vs 20.6%;aHR 0.66,95%CI 0.57-0.76),但6个月病毒抑制无差异(aRR 1.00,95%CI 0.98-1.02)。
要点
- 同日启动ART者失访率27.7%,延迟启动者20.6%,延迟启动与较低失访风险相关(aHR 0.66)。
- 同日启动与延迟启动的6个月病毒抑制无显著差异(aRR 1.00,95%CI 0.98-1.02)。
- 晚期HIV疾病患者同日启动ART的可能性低于早期疾病患者。
核心结论
- 入组当日启动ART者比延迟启动者更常失访,但病毒抑制可能性相当。
- 研究结果支持世界卫生组织近期关于为接受同日启动ART的患者提供定制咨询和支持的建议。
研究设计与样本
- 研究纳入参与国际艾滋病流行病学数据库评估(IeDEA)联盟的63个中心的29017例初治成人HIV感染者,这些患者在Treat-All实施后至2019年1月前入组。
- 使用多变量Cox回归估计同日启动ART与失访的关联,使用Poisson回归估计同日启动ART与6个月病毒抑制的关联。
主要发现
- 29017例患者中,18584例(64.0%)在入组当日启动ART。
- 晚期HIV疾病患者同日启动ART的可能性低于早期疾病患者。
- 延迟启动(≥1天)者失访率20.6%,同日启动者27.7%;调整后风险比0.66(95%CI 0.57-0.76),延迟启动者失访风险显著更低。
- 6个月病毒抑制率按启动时间无差异(调整后率比1.00;95%CI 0.98-1.02)。
临床怎么用
- 世界卫生组织近期建议为接受同日启动ART的患者提供定制咨询和支持。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Treat-All guidelines recommend initiation of antiretroviral therapy (ART) for all people with HIV (PWH) on the day of diagnosis when possible, yet uncertainty exists about the impact of same-day ART initiation on subsequent care engagement. We examined the association of same-day ART initiation with loss to follow-up and viral suppression among patients in 11 sub-Saharan African countries. METHODS: We included ART-naive adult PWH from sites participating in the International epidemiology Databases to Evaluate AIDS (IeDEA) consortium who enrolled in care after Treat-All implementation and prior to January 2019. We used multivariable Cox regression to estimate the association between same-day ART initiation and loss to follow-up and Poisson regression to estimate the association between same-day ART initiation and 6-month viral suppression. RESULTS: Among 29 017 patients from 63 sites, 18 584 (64.0%) initiated ART on the day of enrollment. Same-day ART initiation was less likely among those with advanced HIV disease versus early-stage disease. Loss to follow-up was significantly lower among those initiating ART ≥1 day of enrollment, compared with same-day ART initiators (20.6% vs 27.7%; adjusted hazard ratio: .66; 95% CI .57-.76). No difference in viral suppression was observed by time to ART initiation (adjusted rate ratio: 1.00; 95% CI: .98-1.02). CONCLUSIONS: Patients initiating ART on the day of enrollment were more frequently lost to follow-up than those initiating later but were equally likely to be virally suppressed. Our findings support recent World Health Organization recommendations for providing tailored counseling and support to patients who accept an offer of same-day ART.
引用
- Ross J, Brazier E, Fatti G, et al. Same-Day Antiretroviral Therapy Initiation as a Predictor of Loss to Follow-up and Viral Suppression Among People With Human Immunodeficiency Virus in Sub-Saharan Africa. Clin Infect Dis. 2023. PMID: 36097726. doi:10.1093/cid/ciac759
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。